Chimeric antigen receptor natural killer (CAR-NK) cell therapy is emerging as a promising next-generation immunotherapy with ...

Researchers have unlocked a way to grow the immune system’s “conductors” from stem cells, bringing ready-made cancer-fighting therapies a big step closer. For the first time, scientists at the Univers ...

Cancer immunotherapy has been transformed by engineered T cells, but those bespoke treatments are slow, expensive, and out of ...

Cancer cells employ a variety of strategies to evade the immune system, and modern immunotherapies aim precisely at these ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important ...

About 130 years ago, American physician William Coley injected a terminally ill cancer patient with a lethal cocktail of ...

Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...

Degrader of cancer protein IDO1 prevents cancer immune suppression by cancer and offers promising strategy to support existing immunotherapies ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune ...

Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation AwardExpands iNKT ...

Researchers at the University of British Columbia (UBC) have made a significant discovery regarding the cultivation of ...

One of the ways scientists are trying to improve cancer treatments is by better equipping the body's own immune system to ...